NOIDS.wiki
Kalkulator
Sklep Kalkulator mocy
Nauka o konopiach

CBG (Cannabigerol): Specs, Evidence, Decarb & Infusion

Cannabinoid index · Non-intoxicating

Mother cannabinoidNon-intoxicatingNot approvedWADA-prohibited

CBG (cannabigerol) is a non-intoxicating cannabinoid often called the “mother cannabinoid,” because its acid form CBGA is the precursor the plant uses to build THC, CBD and CBC. Most of it converts as the plant matures, so mature flower usually contains less than 1% CBG.

Specification
Compound
CBG (Cannabigerol)
Acid form
CBGA (cannabigerolic acid), the precursor to the other cannabinoids
Classification
Phytocannabinoid (biosynthetic precursor)
CAS number
25654-31-3
Molecular formula
C21H32O2
Molecular weight
316.48 g/mol
Intoxicating
No
Solubility
Fat-soluble; poorly water-soluble

Decarboxylation & infusion

Acid form
CBGA, which the plant mostly converts into THCA, CBDA and CBCA
Dekarboksylacja
Any remaining CBGA becomes CBG with heat over time
Why it is scarce
By harvest most CBGA has already been converted, leaving little CBG
Infusion
Fat-soluble, so it transfers into oils and butter like the rest

High-CBG material comes from specific cultivars or early harvests. See the tabela temperatur dekarboksylacji.

Evidence & status
Approval status
Not approved. Not a component of any approved drug.
European status
Not authorised. No monograph.
Strongest support
Preclinical: cell and animal studies
Competitive sport
Prohibited in-competition by WADA (cannabinoids, CBD excepted).
Lab workAnimal studiesHuman studiesApproved label

Reviewed 2026-09-04. Not legal or medical advice.

What the published literature examined

CBG’s role as the biosynthetic parent of the other cannabinoids is well established in plant chemistry. Its own pharmacology, including activity at adrenergic and other receptors, has been examined in cell and animal studies, with early interest in anti-inflammatory and antibacterial signals. There is little human clinical data.

What is established, and what is not

Established: that CBGA is the precursor the plant uses to make THC, CBD and CBC, and that CBG is non-intoxicating and active at certain receptors in the lab. Not established: any human clinical effect or approved use; the wellness claims outpace the evidence. This page describes the compound and summarises research; it is not medical advice.

Sources

  • Izzo AA, et al. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci. 2009;30:515-527. PubMed
  • Reviews of cannabigerol pharmacology and cannabinoid biosynthesis. PubMed
  • Registered human studies for cannabigerol. ClinicalTrials.gov
  • World Anti-Doping Agency. Prohibited List (cannabinoids, CBD excepted). wada-ama.org

Frequently asked questions

What is CBG?

CBG, or cannabigerol, is a non-intoxicating minor cannabinoid. Its acid form, CBGA, is the precursor the plant uses to make THC, CBD and other cannabinoids, which is why it is called the “mother cannabinoid.”

Does CBG get you high?

No. CBG is non-intoxicating and does not produce the high associated with THC.

Why is there so little CBG in most cannabis?

Because its precursor CBGA is converted into other cannabinoids as the plant matures. By harvest most has become THCA or CBDA, so mature flower usually tests below 1% CBG.

Part of the cannabinoid index. See also CBN.

Educational information about a compound. Not medical advice or guidance on use.

Ten artykuł służy wyłącznie celom edukacyjnym. Zawsze przestrzegaj lokalnych przepisów dotyczących przygotowania i używania konopi.

Scroll to Top